As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: Jane Street Group LLC, CTC LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Millennium Management LLC, CMT Capital Markets Trading GmbH, Capital Markets Trading UK LLP, Cubist Systematic Strategies LLC, Royal Bank of Canada, Caption Management LLC, Nomura Holdings Inc., DRW Securities LLC, Twin Tree Management LP, Symmetry Peak Management LLC, HAP Trading LLC, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Tradition Wealth Management LLC, Credit Agricole S A, Maven Securities LTD, Marathon Trading Investment Management LLC, Simplex Trading LLC, JPMorgan Chase & Co., Wolverine Asset Management LLC, National Bank of Canada FI, Citigroup Inc., Delta Accumulation LLC, Bank of Nova Scotia, Jefferies Financial Group Inc., Wernau Asset Management Inc., Readystate Asset Management LP, Allianz Asset Management GmbH, Total Wealth Planning & Management Inc., SG Americas Securities LLC, and Total Wealth Planning & Management Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.